The Future of CAR-T Cell Therapy

For me one of the biggest challenges is really going to be how we start to learn to use some of these alternate therapies that are available for the treatment of cytokine release syndrome in eye cancer. The second part of it is also the impact on car efficacy and making sure that we really understand if it's going to have a deleterious effect on overall outcomes. In terms of thinking about cardiac and pulmonary, of optimization and toxicities I'd like to echo of what Dr. Perna had said about getting more information kind of from larger databases.